June 30, 2020
Mereo BioPharma strengthens its management team
Mereo BioPharma has named several new positions this week, thus reaffirming it’s management team with those appointments.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Mereo BioPharma Group
May 15, 2017
Mereo BioPharma wraps up patients testing for its rare pulmonary disease drug
Mereo BioPharma Group, a clinical stage, biopharmaceutical company focused on rare and specialty diseases, has completed patient enrolment in the AETHER, multi-centre, double-blind, placebo-controlled Phase 2 dose-ranging study of acumapimod (BCT-197), for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
May 4, 2017
Mereo BioPharma starts Phase 2 study of rare bone disease drug
Mereo BioPharma Group, a clinical stage, biopharmaceutical company focused on rare and specialty diseases, has initiated a potentially pivotal Phase 2b clinical study of BPS-804 for the treatment of the orphan disease, osteogenesis imperfecta (OI) (brittle bone disease), the ASTEROID study.